Skip to search formSkip to main contentSkip to account menu

minaxolone

Known as: 11Alpha-(Dimethylamino)-2Beta-Ethoxy-3Alpha-Hydroxy-5Alpha-Pregnan-20-One, C.C.I. 12923, Pregnan-20-one, 11-(dimethylamino)-2-ethoxy-3-hydroxy-, (2beta,3alpha,5alpha,11alpha)- 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AnestheticsPregnanolone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1993
Review
1993
Anaesthetic steroids--a review.
Steroids produce anaesthesia besides producing the well known metabolic and hormonal effects. A number of anaesthetic steroids… 
Review
1983
Review
1983
New drugs — boon or bane? Premedication and intravenous induction agents
  • R. Clarke
  • Canadian Anaesthetists' Society journal
  • 1983
  • Corpus ID: 37538807
Research on the benzodiazepines has shown that they have certain advantages over the opiates as premedicants. Diazepam, which… 
1981
1981
Alphadione and minaxolone pharmacokinetics.
Althesin (alphaxalone: alphadolone acetate) and the new water-soluble steroid intravenous anaesthetic agent minaxolone have been… 
1981
1981
Studies on premedication and ventilatory responses to minaxolone.
The effect of three premedications on induction, maintenance and recovery characteristics of minaxolone as a supplement to… 
1981
1981
Clinical trial — the minaxolone story
  • C. Hope
  • Canadian Anaesthetists' Society journal
  • 1981
  • Corpus ID: 32977595
1980
1980
Early Clinical Evaluation of Minaxolone: A New Intravenous Steroid Anaesthetic Agent
1980
1980
THE PHARMACOKINETICS AND PHARMACODYNAMICS OF MINAXOLONE
1979
1979
Cardiovascular studies during induction with minaxolone.
The cardiovascular effects of induction of anesthesia with minaxolone, a new water soluble steroid agent, have been studied in 12… 
1979
1979
The influence of dosage and premedication on induction of anesthesia with minaxolone.
Minaxolone, a new steroid induction agent, was administered to unpremedicated patients at three dose levels and at 0.5 mg . kg-1…